Celldex Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $98M | 3.9M | 25.27 |
| 2024-09-30 | $132M | 3.9M | 33.99 |
| 2024-06-30 | $138M | 3.7M | 37.01 |
| 2024-03-31 | $153M | 3.7M | 41.97 |
| 2023-12-31 | $121M | 3.0M | 39.66 |
| 2023-09-30 | $72M | 2.6M | 27.52 |
| 2023-06-30 | $88M | 2.6M | 33.93 |
| 2023-03-31 | $92M | 2.5M | 35.98 |
| 2022-12-31 | $112M | 2.5M | 44.57 |
| 2022-06-30 | $66M | 2.4M | 26.96 |
| 2022-03-31 | $83M | 2.4M | 34.06 |
| 2021-09-30 | $123M | 2.3M | 53.99 |
| 2021-06-30 | $66M | 2.0M | 33.44 |
| 2021-03-31 | $37M | 1.8M | 20.67 |
| 2020-12-31 | $31M | 1.8M | 17.59 |
| 2020-09-30 | $26M | 1.7M | 14.83 |
| 2020-06-30 | $17M | 1.3M | 13.08 |
| 2020-03-31 | $893k | 538k | 1.66 |
| 2019-12-31 | $1.2M | 516k | 2.23 |
| 2019-09-30 | $1.0M | 516k | 1.95 |
| 2019-03-31 | $2.4M | 488k | 4.88 |